Clinical Trial Update: Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study [Phase 2]

View source ↗

Summary

This is a Phase 2 prospective exploratory trial evaluating a multi-drug regimen (liposomal irinotecan, 5-fluorouracil with leucovorin, oxaliplatin) plus the PD-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Adebrelimab (adebrelimab)
• Calcium folinate (calcium folinate)
• Liposomal irinotecan (Onivyde) (irinotecan liposome)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Ningbo Medical Center Lihuili Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING